腺苷脱氨酶2作为全身型幼年特发性关节炎巨噬细胞活化综合征的生物标志物
本研究在324名健康儿童和成人中建立外周血ADA2活性年龄相关正常范围,并与173名炎症及免疫介导疾病患儿比较,发现ADA2升高主要限于合并MAS的sJIA患者,且与铁蛋白、IL-18、CXCL9等MAS标志物强相关,而与CRP和ESR关联微弱,提示血浆ADA2活性可作为MAS的生物标志物。
要点
- ADA2活性超出正常上限在儿童中主要见于合并MAS的sJIA患者
- ADA2活性与铁蛋白、IL-18、CXCL9等MAS标志物强相关,与CRP和ESR关联微弱
- ADA2活性随复发性MAS患者的系列测量与疾病活动度平行
核心结论
- 血浆ADA2活性可作为巨噬细胞活化综合征(MAS)的生物标志物,并支持巨噬细胞活化在该病中的关键作用。
研究设计与样本
- 在324名健康儿童和成人中建立外周血ADA2活性的年龄相关正常范围。
- 将上述范围与173名炎症及免疫介导疾病患儿进行比较,包括全身型和非全身型JIA、川崎病、儿童系统性红斑狼疮和幼年皮肌炎。
- 在sJIA患者验证队列中确认ADA2升高与MAS的关联,该队列包括疾病不活动、活动性sJIA无MAS及sJIA合并MAS患者。
主要发现
- ADA2升高超出儿童正常上限主要局限于合并MAS的sJIA患者,该发现在验证队列中得到确认。
- ADA2活性与MAS生物标志物铁蛋白、白细胞介素(IL)-18和干扰素(IFN)-γ诱导趋化因子CXCL9强相关。
- ADA2活性与炎症标志物C反应蛋白和红细胞沉降率关联微弱。
- 在复发性MAS episodes患者中,系列测量显示ADA2与疾病活动度平行。
- IL-18和IFN-γ可诱导外周血单个核细胞产生ADA2,且ADA2在MAS噬血细胞中丰富存在。
临床怎么用
- 在sJIA患者中,血浆ADA2活性升高超出年龄相关正常上限应警惕合并MAS的可能。
- ADA2活性可与铁蛋白、IL-18、CXCL9等MAS标志物联合用于评估疾病活动度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile idiopathic arthritis (sJIA) characterised by a vicious cycle of immune amplification that can culminate in overwhelming inflammation and multiorgan failure. The clinical features of MAS overlap with those of active sJIA, complicating early diagnosis and treatment. We evaluated adenosine deaminase 2 (ADA2), a protein of unknown function released principally by monocytes and macrophages, as a novel biomarker of MAS. METHODS: We established age-based normal ranges of peripheral blood ADA2 activity in 324 healthy children and adults. We compared these ranges with 173 children with inflammatory and immune-mediated diseases, including systemic and non-systemic JIA, Kawasaki disease, paediatric systemic lupus erythematosus and juvenile dermatomyositis. RESULTS: ADA2 elevation beyond the upper limit of normal in children was largely restricted to sJIA with concomitant MAS, a finding confirmed in a validation cohort of sJIA patients with inactive disease, active sJIA without MAS or sJIA with MAS. ADA2 activity strongly correlated with MAS biomarkers including ferritin, interleukin (IL)-18 and the interferon (IFN)-γ-inducible chemokine CXCL9 but displayed minimal association with the inflammatory markers C reactive protein and erythrocyte sedimentation rate. Correspondingly, ADA2 paralleled disease activity based on serial measurements in patients with recurrent MAS episodes. IL-18 and IFN-γ elicited ADA2 production by peripheral blood mononuclear cells, and ADA2 was abundant in MAS haemophagocytes. CONCLUSIONS: These findings collectively identify the utility of plasma ADA2 activity as a biomarker of MAS and lend further support to a pivotal role of macrophage activation in this condition.
引用
- Lee PY, Schulert GS, Canna SW, et al. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2019. PMID: 31707357. doi:10.1136/annrheumdis-2019-216030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。